The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction

Not Applicable

Recruiting

• Conditions: Prostate Adenocarcinoma
• Interventions: Diagnostic Test: Ulrasound Vibroelastography (UVE)

• Registration Number: NCT05109208
• Lead Sponsor: Mayo Clinic

Brief Summary

Researchers are trying to determine whether there is additional utility to using vibroelastography, a noninvasive ultrasound technique to evaluate for the presence of tissue fibrosis, in conjunction with standard penile duplex Doppler ultrasound to assess erectile function (recovery) after prostate cancer surgery.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-10-26
• Study First Submitted QC: 2021-10-26
• Study First Posted: 2021-11-05
• Study Start: 2023-10-02
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-12
• Last Update Posted: 2024-03-15
• Primary Completion: 2025-10
• Study Completion: 2025-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Ultrasound viscoelastography (UVE) in radical proctectomy recovery	Ulrasound Vibroelastography (UVE)	Subjects undergoing radical prostatectomy for prostate cancer disease as standard of care will have a ultrasound vibroelastography performed before surgery, 3 months, 6 months and 9 months post-prostatectomy.

Primary Outcome Measures

Name	Time	Method
Change in Viscoelasticity	Baseline, 3 months, 6 months and 9 months post-prostatectomy	As measured by Ultrasound Vibroelastography (UVE)

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States